Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Abstract: We consider the problem of translating XML queries into SQL when XML documents have been stored in an RDBMS using a schema-based relational decomposition. Surprisingly, there is no published ...

The lack of a recursion depth limit in the oracle's price calculation logic will cause a permanent Denial of Service for any misconfigured markets, affecting all users of those markets. A trusted ...

Abstract: Recursion is a fundamental computation mechanism which has been incorporated into the SQL language. This work focuses on the optimization of linear recursive queries in SQL. Query ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...

The business of using artificial intelligence to find new drugs is starting to consolidate. The AI-powered drug discovery firm Recursion Pharmaceuticals will buy rival Exscientia in an all-stock deal ...